文献速递银屑病与炎症性皮肤病

美国COVID-19大流行期间银屑病和银屑病关节炎超额死亡率:2010至2021年全国性人群研究

Excess psoriasis and psoriatic arthritis mortality during the COVID-19 pandemic in the United States: A nationwide population-based study from 2010 to 2021.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-02-28

该研究基于美国国家生命统计系统数据,分析2010至2021年银屑病(PsO)和银屑病关节炎(PsA)的年龄标准化死亡率(ASMR)趋势,并与预测值比较。结果显示2020-2021年PsO和PsA的ASMR显著上升,PsO的ASMR在2020和2021年分别高于预测值(0.27 vs 0.22 和 0.31 vs 0.23),超额死亡率分别达16.4%和19.8%,SARS-CoV-2感染贡献超过60%的超额死亡。女性及中年组ASMR上升最明显。

要点

  • 2020-2021年PsO的ASMR年变化百分比(APC)为15.26%,显著高于2010-2019年的2.07%(p<0.01)。
  • PsO的ASMR在2020年和2021年分别为0.27和0.31(每10万人),均高于预测值0.22和0.23。
  • PsO和PsA的超额死亡中SARS-CoV-2感染贡献超过60%。

核心结论

  • 银屑病和银屑病关节炎患者在COVID-19大流行期间受到不成比例的影响,ASMR以惊人速度上升,女性和中年组差异最明显。

研究设计与样本

  • 基于美国国家生命统计系统的全国性人群研究,纳入2010至2021年5810例银屑病相关死亡和2150例银屑病关节炎相关死亡。

主要发现

  • 2010-2019年与2020-2021年银屑病ASMR的年变化百分比分别为2.07%和15.26%(p<0.01)。
  • 2020年银屑病观察ASMR为0.27(每10万人),预测值为0.22;2021年观察ASMR为0.31,预测值为0.23。
  • 银屑病超额死亡率在2020年为16.4%(95% CI: 14.9%-17.9%),2021年为19.8%(95% CI: 18.0%-21.6%)。
  • 银屑病ASMR上升在女性(APC 26.86% vs 男性12.19%)和中年组(APC 17.67% vs 老年组12.47%)更明显。
  • 银屑病关节炎的ASMR、APC和超额死亡率与银屑病相似;SARS-CoV-2感染贡献银屑病和银屑病关节炎超额死亡的60%以上。

关键数值与推荐

  • 银屑病ASMR在2020年观察值0.27 vs 预测值0.22,在2021年观察值0.31 vs 预测值0.23(每10万人)。
  • 银屑病超额死亡率2020年16.4%(95% CI: 14.9%-17.9%),2021年19.8%(95% CI: 18.0%-21.6%)。
  • 银屑病ASMR年变化百分比2010-2019年2.07% vs 2020-2021年15.26%(p<0.01)。
  • 女性银屑病ASMR年变化百分比26.86% vs 男性12.19%;中年组17.67% vs 老年组12.47%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about mortality trends among patients with psoriasis (PsO) and psoriatic arthritis (PsA) in the United States. OBJECTIVES: To ascertain mortality trends of PsO and PsA between 2010 and 2021, focusing on the effects of the COVID-19 pandemic. METHODS: We collected data from the National Vital Statistic System and calculated age-standardized mortality rates (ASMR) and cause-specific mortality for PsO/PsA. We evaluated observed versus predicted mortality for 2020-2021 based on trends from 2010 to 2019 with joinpoint and prediction modelling analysis. RESULTS: Among 5810 and 2150 PsO- and PsA-related deaths between 2010 and 2021, ASMR for PsO dramatically increased between 2010-2019 and 2020-2021 (annual percentage change [APC] 2.07% vs. 15.26%; p < 0.01), leading to a higher observed ASMR (per 100,000 persons) than predicted for 2020 (0.27 vs. 0.22) and 2021 (0.31 vs. 0.23). The excess mortality of PsO was 22.7% and 34.8% higher than that in the general population in 2020 (16.4%, 95% CI: 14.9%-17.9%) and 2021 (19.8%, 95% CI: 18.0%-21.6%) respectively. Notably, the ASMR rise for PsO was most pronounced in the female (APC: 26.86% vs. 12.19% in males) and the middle-aged group (APC: 17.67% vs. 12.47% in the old-age group). ASMR, APC and excess mortality for PsA were similar to PsO. SARS-CoV-2 infection contributed to more than 60% of the excess mortality for PsO and PsA. CONCLUSIONS: Individuals living with PsO and PsA were disproportionately affected during the COVID-19 pandemic. Both ASMRs increased at an alarming rate, with the most pronounced disparities among the female and middle-aged groups.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Liu Y, He X, Lee EY, et al. Excess psoriasis and psoriatic arthritis mortality during the COVID-19 pandemic in the United States: A nationwide population-based study from 2010 to 2021. J Eur Acad Dermatol Venereol. 2023. PMID: 36808772. doi:10.1111/jdv.18978

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。